Cargando…
Host Genetic Variants in the Pathogenesis of Hepatitis C
Direct-acting antiviral drugs (DAAs) are currently replacing antiviral therapy for Hepatitis C infection. Treatment related side effects are even worse and the emergence of resistant viruses must be avoided because of the direct-antiviral action. Altogether it remains a challenge to take treatment d...
Autores principales: | Rau, Monika, Baur, Katharina, Geier, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528266/ https://www.ncbi.nlm.nih.gov/pubmed/23342360 http://dx.doi.org/10.3390/v4123281 |
Ejemplares similares
-
Screening for nonalcoholic fatty liver disease-when, who and how?
por: Dietrich, Christoph G, et al.
Publicado: (2021) -
Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry
por: Rau, Monika, et al.
Publicado: (2022) -
Role of Host Genetic Factors in the Outcome of Hepatitis C Virus Infection
por: Bengsch, Bertram, et al.
Publicado: (2009) -
Host Genetics of Cytomegalovirus Pathogenesis
por: Sezgin, Efe, et al.
Publicado: (2019) -
Pathogenesis of Hepatitis C During Pregnancy and Childhood
por: Le Campion, Armelle, et al.
Publicado: (2012)